Biotech · Private company
WinSanTor, Inc
Track this companyFree. Adds WinSanTor, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Active: WST-057 4mL (146 mg pirenzepine free base monohydrate) topical solutionPhase 2 · Painful Diabetic NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- WST-057Phase 2 · HIV Associated PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- WST-057 ActivePhase 2 · Chemotherapy-induced Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral NeuropathyPHASE2 · UNKNOWN · started Nov 22, 2022ClinicalTrials.gov NCT05488873 · fetched Nov 12, 2026
- A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIVPHASE2 · COMPLETED · started Feb 24, 2022ClinicalTrials.gov NCT05005078 · fetched Nov 12, 2026
- A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral NeuropathyPHASE2 · COMPLETED · started Nov 20, 2020ClinicalTrials.gov NCT04786340 · fetched Nov 12, 2026